Start Magazine

The START Center for Cancer Research is a global leader in early-phase oncology clinical trials, operating one of the world's largest networks of Phase I clinical research sites. Founded in 2007 and headquartered in San Antonio, Texas, the organization provides pharmaceutical and biotechnology companies with specialized services for the clinical development of novel anti-cancer agents. START's mission is to accelerate the development of new cancer drugs by providing community access to early-phase trials, having contributed to the development of over 45 therapies that have received FDA or EMA approval. The center maintains a global presence with numerous sites across the United States and Europe, including partnerships with major health systems like Northwell Health.